Fig. 4: Willingness to consider participation in a gene therapy trial for cardiomyopathy.
Proportion of respondents who would consider participation in a gene therapy trial for cardiomyopathy in the six scenarios shown in Table 1.
Fig. 4: Willingness to consider participation in a gene therapy trial for cardiomyopathy. | European Journal of Human Genetics
